Literature DB >> 2317482

Age-related changes in the activity of the pyruvate carrier and in the lipid composition in rat-heart mitochondria.

G Paradies1, F M Ruggiero.   

Abstract

The effect of aging on the activity of the pyruvate translocator and on the lipid composition in rat-heart mitochondria has been investigated. It has been found that the rate of pyruvate transport in mitochondria from aged rats (28 months old) is markedly reduced (38%) as compared with that obtained with mitochondria from young adults rats (4 months old). Kinetic analysis of the pyruvate transport shows that only the Vmax of this process is decreased, while there is no change in the Km values. The age-related decrement in the activity of the pyruvate carrier is not due to a decrease in the transmembrane delta pH value, neither does it depend on a decrease in the total number of the pyruvate carrier molecules, titrated with radioactive alpha-cyanocinnamate. The lower activity of the pyruvate translocator in mitochondria from aged rats is associated to a parallel decrement of the rate of pyruvate-dependent oxygen uptake. There is, however no appreciable difference in either the respiratory control ratios or in the ADP/O ratios between these two types of mitochondrion. The Arrhenius plot characteristics differ for pyruvate transport activity in mitochondria from aged rats as compared with young rats in that the break point of the biphasic plot is shifted to a higher temperature. The heart mitochondrial lipid composition is significantly altered in aged rats. The total cholesterol increases (43%), the phospholipids decrease (15%) and the cholesterol/phospholipid molar ratio increases (68%). Among phospholipids, cardiolipin shows the greatest alteration (28% decrease in aged rats). The lower activity of the pyruvate carrier in mitochondria from aged rats may be ascribed to changes in the lipid domain surrounding the carrier molecule in the membrane.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317482     DOI: 10.1016/0005-2728(90)90060-h

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  28 in total

Review 1.  First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics.

Authors:  Hazel H Szeto
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 2.  Mitochondrial cholesterol: mechanisms of import and effects on mitochondrial function.

Authors:  Laura A Martin; Barry E Kennedy; Barbara Karten
Journal:  J Bioenerg Biomembr       Date:  2014-11-26       Impact factor: 2.945

3.  Reduced oxidative power but unchanged antioxidative capacity in skeletal muscle from aged humans.

Authors:  Michail Tonkonogi; Maria Fernström; Brandon Walsh; Li Li Ji; Olav Rooyackers; Folke Hammarqvist; Jan Wernerman; Kent Sahlin
Journal:  Pflugers Arch       Date:  2003-03-27       Impact factor: 3.657

Review 4.  Mitochondrial function in hypoxic ischemic injury and influence of aging.

Authors:  P Benson Ham; Raghavan Raju
Journal:  Prog Neurobiol       Date:  2016-06-16       Impact factor: 11.685

Review 5.  The functions of cardiolipin in cellular metabolism-potential modifiers of the Barth syndrome phenotype.

Authors:  Vaishnavi Raja; Miriam L Greenberg
Journal:  Chem Phys Lipids       Date:  2014-01-17       Impact factor: 3.329

Review 6.  Mitochondrial pyruvate transport: a historical perspective and future research directions.

Authors:  Kyle S McCommis; Brian N Finck
Journal:  Biochem J       Date:  2015-03-15       Impact factor: 3.857

7.  Docosahexaenoic acid- and eicosapentaenoic acid-enriched cardiolipin in the Manila clam Ruditapes philippinarum.

Authors:  Edouard Kraffe; Philippe Soudant; Yanic Marty; Nelly Kervarec
Journal:  Lipids       Date:  2005-06       Impact factor: 1.880

Review 8.  Oxidative damage and mitochondrial decay in aging.

Authors:  M K Shigenaga; T M Hagen; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

Review 9.  Cardiac aging and insulin resistance: could insulin/insulin-like growth factor (IGF) signaling be used as a therapeutic target?

Authors:  Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Loss of cardiolipin leads to longevity defects that are alleviated by alterations in stress response signaling.

Authors:  Jingming Zhou; Quan Zhong; Guiling Li; Miriam L Greenberg
Journal:  J Biol Chem       Date:  2009-04-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.